The blog is about health and gives useful information on health and disease.

Wherever one turns – America, Canada, Kenya, Britain – there is a struggle to get this 30-year established treatment accepted by either government health schemes or private insurance companies – companies who are quite prepared to pay for a treatment such as bypass surgery which will cost them on average ten times more than a course of chelation. What deters them?

The safety of chelation therapy is not in question. That has been established by long experience with treatments for which EDTA is accepted protocol, such as a blood condition known as thalassaemia, or for heavy metal poisoning.

What is not proved to medical requirements (double-blind trials) is its efficacy in treating circulatory disease. However, there have been some 200 scientific studies concentrating on the specific effects of EDTA in circulatory disease (more than have ever been done, as stated earlier, in respect to the medical procedures of bypass surgery and angioplasty) and these, plus overwhelmingly positive empirical evidence, must surely present sufficient grounds for experimental use in certain areas.

For example, what about those medicines that can’t help any more? Those patients whom the medical profession calls by the rather besmirching term of’ ‘refractory’? Since chelation is safe and they have been given up anyway what have they – or anyone else – to lose?

*94\104\2*

Cardio & Blood/ Cholesterol